Kenvue Inc (KVUE) reports modest growth and outlines strategic initiatives to overcome market challenges and drive future innovation.

Shares of Kenvue Inc. KVUE slipped 4.53% to $19.80 Thursday, on what proved to be an all-around mixed trading session for the ...

Q4 2024 Management View CEO Thibaut Mongon acknowledged organic sales growth for the year at 1.5%, falling below expectations due to lower incidences of cold, cough, and flu, and reduced distributor ...

Operator Hello, and welcome to the Kenvue fourth-quarter and full-year 2024 earnings conference call. [Operator instructions] ...

The S&P 500 Index ($SPX) (SPY) today is up +0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.12%, and the Nasdaq ...

Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and ...

For the quarter ended December 2024, Kenvue (KVUE) reported revenue of $3.66 billion, down 0.1% over the same period last year. EPS came in at $0.26, compared to $0.31 in the year-ago quarter. The ...

Kenvue (KVUE) came out with quarterly earnings of $0.26 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.31 per share a year ago. These figures are adjusted for ...

Pure-play consumer health company Kenvue Inc. (KVUE) , while reporting weak fourth-quarter profit, in line with market, on Thursday ...

Kenvue Inc. (KVUE) reported a profit for fourth quarter that decreased from last year in line with the Street estimates. The ...

Consumer health company Kenvue forecast 2025 adjusted profit below Wall Street estimates on Thursday, hit by a stronger ...

S&P 500 E-Mini futures (ESH25) are up +0.20%, andMarch Nasdaq 100 E-Mini futures (NQH25) are up +0.10% this morning, ...